Filing Details

Accession Number:
0001567619-22-006732
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-10 20:26:11
Reporting Period:
2022-03-08
Accepted Time:
2022-03-10 20:26:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1882643 W. Terry Lubben C/O Treace Medical Concepts, Inc.
203 Fort Wade Road, Suite 150
Ponte Vedra FL 32081
Svp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-08 3,350 $0.00 3,350 No 4 A Direct
Common Stock Acquisiton 2022-03-08 2,500 $18.62 5,850 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-03-08 25,800 $0.00 25,800 $19.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,800 2032-03-08 No 4 A Direct
Footnotes
  1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
  2. Includes 3,350 RSUs.
  3. The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $18.347 to $18.65 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.